About HospiraNews & MediaInvestor RelationsIn the CommunitySearch :  
Home




The Opticath Central Venous Oximetry Probe monitors central venous oxyhemoglobin saturation continuously when used in conjunction with a previously placed central venous catheter.

This probe utilizes Hospira's exclusive 3-wavelength technology with digital filtration to provide proven performance. This technology may also eliminate the need for clinical updates of hemoglobin/hematocrit values. The Opticath system's light intensity display helps ensure accurate readings and proper probe placement.

  • Works with all existing Hospira SO2 Monitors — Oximetrix 3, Q2 and Q2 Plus
  • Compatible with SO2 modules manufactured by Philips Medical, GE Medical and Spacelabs Medical, eliminating the need for an additional stand-alone monitor
  • May eliminate the need to exchange central venous catheters in order to monitor ScvO2 continuously
  • Permits scalable use of technology and may provide more efficient resource utilization
  • May be used for the following:
    • As a component of early goal directed therapy (EGDT)
    • Rapid continuous assessment of a patient's hemodynamic status
    • Management of ventilation patterns and PEEP adjustment
    • As an indication of changing oxygen transport variables: cardiac output, hemoglobin and oxygen demand
This Web site and its information is intended for use by United States residents only. Countries outside the United States may have regulatory requirements, data requirements or medical practices that differ from the United States and, therefore, this information may be inappropriate for use outside the United States. Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, contact Hospira.
9-084